PNMA6E
gene geneOn this page
Summary
PNMA6E (PNMA family member 6E, HGNC:50767) is a protein-coding gene on chromosome Xq28, encoding Paraneoplastic antigen Ma6E (A0A0J9YXQ4).
At a glance
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001367770
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50767 |
| Approved symbol | PNMA6E |
| Name | PNMA family member 6E |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214897 |
| Ensembl biotype | protein_coding |
| Entrez | 649238 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000445091, ENST00000633844
RefSeq mRNA: 3 — MANE Select: NM_001367770
NM_001351293, NM_001351294, NM_001367770
CCDS: CCDS87793, CCDS94694
Canonical transcript exons
ENST00000445091 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001675703 | 153395639 | 153398920 |
| ENSE00003780347 | 153401244 | 153401350 |
Expression profiles
Bgee: expression breadth broad, 21 present calls, max score 75.64.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0478 / max 34.4161, expressed in 6 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200865 | 0.0256 | 5 |
| 200866 | 0.0221 | 4 |
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 75.64 | gold quality |
| left testis | UBERON:0004533 | 73.37 | gold quality |
| testis | UBERON:0000473 | 73.30 | gold quality |
| left ovary | UBERON:0002119 | 55.30 | gold quality |
| ovary | UBERON:0000992 | 54.49 | gold quality |
| right ovary | UBERON:0002118 | 51.65 | gold quality |
| left uterine tube | UBERON:0001303 | 49.86 | gold quality |
| colonic epithelium | UBERON:0000397 | 48.52 | silver quality |
| apex of heart | UBERON:0002098 | 43.89 | silver quality |
| fallopian tube | UBERON:0003889 | 43.29 | gold quality |
| sural nerve | UBERON:0015488 | 43.21 | gold quality |
| placenta | UBERON:0001987 | 42.19 | silver quality |
| bone marrow cell | CL:0002092 | 41.00 | gold quality |
| bone marrow | UBERON:0002371 | 40.95 | gold quality |
| right uterine tube | UBERON:0001302 | 40.94 | silver quality |
| left adrenal gland cortex | UBERON:0035825 | 40.16 | gold quality |
| left adrenal gland | UBERON:0001234 | 39.54 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 38.42 | silver quality |
| adrenal gland | UBERON:0002369 | 38.41 | gold quality |
| pituitary gland | UBERON:0000007 | 36.90 | gold quality |
| adenohypophysis | UBERON:0002196 | 36.65 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right coronary artery | UBERON:0001625 | 34.94 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.80 | gold quality |
| prefrontal cortex | UBERON:0000451 | 33.37 | gold quality |
| muscle tissue | UBERON:0002385 | 33.20 | gold quality |
| monocyte | CL:0000576 | 33.00 | gold quality |
| prostate gland | UBERON:0002367 | 32.78 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.48 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pnma6e | ENSMUSG00000096966 |
| mus_musculus | Gm45015 | ENSMUSG00000109368 |
| rattus_norvegicus | Pnma6e | ENSRNOG00000070467 |
Paralogs (13): MOAP1 (ENSG00000165943), ZCCHC18 (ENSG00000166707), CCDC8 (ENSG00000169515), ZCCHC12 (ENSG00000174460), PNMA1 (ENSG00000176903), PNMA8A (ENSG00000182013), PNMA3 (ENSG00000183837), PNMA5 (ENSG00000198883), PNMA8B (ENSG00000204851), PNMA6F (ENSG00000225110), PNMA6A (ENSG00000235961), PNMA2 (ENSG00000240694), PNMA8C (ENSG00000277531)
Protein
Protein identifiers
Paraneoplastic antigen Ma6E — A0A0J9YXQ4 (reviewed: A0A0J9YXQ4)
All UniProt accessions (2): A0A0J9YXH5, A0A0J9YXQ4
RefSeq proteins (3): NP_001338222, NP_001338223, NP_001354699* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026523 | PNMA | Family |
| IPR048270 | PNMA_C | Domain |
| IPR048271 | PNMA_N | Domain |
Pfam: PF14893, PF20846
UniProt features (10 total): compositionally biased region 5, region of interest 4, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A0J9YXQ4-F1 | 56.18 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
chrXq28, ZNF547_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
590 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PNMA6E | PNMA8B | Q9ULN7 | 596 |
| PNMA6E | CT47A11 | Q5JQC4 | 479 |
| PNMA6E | CCDC8 | Q9H0W5 | 397 |
| PNMA6E | ERF | P50548 | 370 |
| PNMA6E | KRTAP2-1 | Q9BYU5 | 370 |
| PNMA6E | CHCT1 | Q86WR6 | 368 |
| PNMA6E | DEFB123 | Q8N688 | 365 |
| PNMA6E | KBTBD12 | Q3ZCT8 | 350 |
| PNMA6E | KRTAP2-2 | Q9BYT5 | 348 |
| PNMA6E | CSKMT | A8MUP2 | 320 |
| PNMA6E | PNMA8C | A0A1B0GUJ8 | 308 |
| PNMA6E | SAXO2 | Q658L1 | 305 |
| PNMA6E | UMPS | P11172 | 303 |
| PNMA6E | ARHGEF33 | A8MVX0 | 300 |
| PNMA6E | ACSM4 | P0C7M7 | 281 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A0J9YX94, A0A0J9YXQ4, A0A0J9YY54, A0A494C1R9, A5D7L8, A6NDY0, A6NKD2, A7E321, E9PGG2, F6SZT2, O14771, O19110, O75807, O88852, P0CV98, P0CV99, P0CW00, P0CW01, P0CW24, P17564, P78358, Q01534, Q0P5N2, Q15735, Q2KI51, Q2M329, Q587J8, Q5DTT8, Q5R5G8, Q5R6R8, Q5SV97, Q60465, Q62881, Q69ZB3, Q6P752, Q86V59, Q8BSI6, Q8IWY8, Q8N3D4, Q8VD63
Diamond homologs: A0A0J9YX94, A0A0J9YXQ4, A0A1B0GUJ8, A6QLK5, A7E321, P0CG32, P0CW24, Q08DL1, Q2KIT6, Q5HZA3, Q5R6R8, Q6PEW1, Q80VM8, Q86V59, Q8JZW8, Q8ND90, Q8VD24, Q8VHZ4, Q9CZA5, Q9UL41, Q9ULN7, D3YZV8, P62521, Q5DTT8, Q5R486, Q8BHK0, Q8C1C8, Q95KI4, Q96BY2, Q96PV4, Q9ERH6, Q9GMU3, Q9H0W5, Q9UL42
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
404 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:153398641:G:C | donor_gain | 1.0000 |
| X:153401240:TCA:T | donor_loss | 1.0000 |
| X:153401242:A:AC | donor_gain | 1.0000 |
| X:153401242:ACT:A | donor_loss | 1.0000 |
| X:153401243:C:CC | donor_gain | 1.0000 |
| X:153401243:CTTT:C | donor_gain | 1.0000 |
| X:153398740:T:TA | donor_gain | 0.9900 |
| X:153398917:CAGC:C | acceptor_gain | 0.9900 |
| X:153398921:C:CC | acceptor_gain | 0.9900 |
| X:153398922:T:G | acceptor_loss | 0.9900 |
| X:153401170:T:TA | donor_gain | 0.9900 |
| X:153401238:ACT:A | donor_loss | 0.9900 |
| X:153401242:ACTTT:A | donor_gain | 0.9900 |
| X:153401243:CT:C | donor_gain | 0.9900 |
| X:153401243:CTT:C | donor_gain | 0.9900 |
| X:153401243:CTTTC:C | donor_gain | 0.9900 |
| X:153401246:T:A | donor_gain | 0.9900 |
| X:153398640:A:AC | donor_gain | 0.9800 |
| X:153398640:AG:A | donor_gain | 0.9800 |
| X:153398751:ATGTT:A | donor_gain | 0.9800 |
| X:153401239:CTCA:C | donor_gain | 0.9800 |
| X:153398647:TC:T | donor_gain | 0.9700 |
| X:153398648:CC:C | donor_gain | 0.9700 |
| X:153398709:G:A | donor_gain | 0.9700 |
| X:153398927:G:GC | acceptor_gain | 0.9700 |
| X:153401183:T:TA | donor_gain | 0.9700 |
| X:153398918:AGC:A | acceptor_gain | 0.9600 |
| X:153398927:G:C | acceptor_gain | 0.9600 |
| X:153398916:ACAGC:A | acceptor_gain | 0.9500 |
| X:153398917:CAGCC:C | acceptor_gain | 0.9500 |
AlphaMissense
4102 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:153398643:G:C | F69L | 0.975 |
| X:153398643:G:T | F69L | 0.975 |
| X:153398645:A:G | F69L | 0.975 |
| X:153397575:G:C | F425L | 0.974 |
| X:153397575:G:T | F425L | 0.974 |
| X:153397577:A:G | F425L | 0.974 |
| X:153398745:G:C | F35L | 0.967 |
| X:153398745:G:T | F35L | 0.967 |
| X:153398747:A:G | F35L | 0.967 |
| X:153397656:A:C | F398L | 0.963 |
| X:153397656:A:T | F398L | 0.963 |
| X:153397658:A:G | F398L | 0.963 |
| X:153397617:G:C | F411L | 0.962 |
| X:153397617:G:T | F411L | 0.962 |
| X:153397619:A:G | F411L | 0.962 |
| X:153397407:G:C | F481L | 0.960 |
| X:153397407:G:T | F481L | 0.960 |
| X:153397409:A:G | F481L | 0.960 |
| X:153398746:A:G | F35S | 0.956 |
| X:153398585:A:G | W89R | 0.955 |
| X:153398585:A:T | W89R | 0.955 |
| X:153397561:T:A | E430V | 0.953 |
| X:153398773:A:G | I26T | 0.946 |
| X:153397878:A:C | F324L | 0.943 |
| X:153397878:A:T | F324L | 0.943 |
| X:153397880:A:G | F324L | 0.943 |
| X:153398782:A:G | I23T | 0.943 |
| X:153397762:A:G | L363P | 0.941 |
| X:153398583:C:A | W89C | 0.940 |
| X:153398583:C:G | W89C | 0.940 |
dbSNP variants (sampled 300 via entrez): RS1000193816 (X:153411401 C>T), RS1000363661 (X:153402026 T>C), RS1000394886 (X:153402408 T>C), RS1000577523 (X:153396539 T>C), RS1000906407 (X:153396428 C>T), RS1001575798 (X:153403250 T>A), RS1001732311 (X:153396688 G>A), RS1001836334 (X:153411921 G>A,C,T), RS1002419299 (X:153409126 C>G,T), RS1002880349 (X:153409280 C>T), RS1003104422 (X:153413610 T>A,C), RS1004581552 (X:153401812 T>A,G), RS1004638100 (X:153396267 G>T), RS1004951021 (X:153401620 C>T), RS1005173782 (X:153405434 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.